Ainos, Inc. (AIMD)
NASDAQ: AIMD · Real-Time Price · USD
3.430
-0.020 (-0.58%)
At close: Sep 17, 2025, 4:00 PM EDT
3.540
+0.110 (3.21%)
Pre-market: Sep 18, 2025, 8:31 AM EDT
Ainos Revenue
Ainos had revenue of $4.66K in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to $110.87K, up 70.25% year-over-year. In the year 2024, Ainos had annual revenue of $20.73K, down -83.02%.
Revenue (ttm)
$110.87K
Revenue Growth
+70.25%
P/S Ratio
96.25
Revenue / Employee
$2,520
Employees
44
Market Cap
16.32M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 20.73K | -101.38K | -83.02% |
| Dec 31, 2023 | 122.11K | -3.40M | -96.53% |
| Dec 31, 2022 | 3.52M | 2.93M | 491.97% |
| Dec 31, 2021 | 594.56K | 578.00K | 3,489.71% |
| Dec 31, 2020 | 16.56K | 4.83K | 41.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
AIMD News
- 1 day ago - Ainos and Topco Sign Distribution Agreement to Accelerate Global Expansion of AI Nose - Accesswire
- 9 days ago - Ainos to Showcase AI Nose at SEMICON Taiwan 2025 - Accesswire
- 22 days ago - Water Tower Research Fireside Chat with Ainos: AI Nose Sets New Bar in AI Scent Digitization, Eyes 2026 Scale-Up - Accesswire
- 4 weeks ago - Water Tower Research Initiates Technology Coverage of Ainos, Highlighting Its Leadership and Advancement in AI-Powered Olfactory Innovation - Accesswire
- 4 weeks ago - Ainos Debuts World's First Patented AI Nose Device, Bringing Machine Scent Intelligence to Industry and Healthcare - Accesswire
- 5 weeks ago - Ainos Reports Second Quarter 2025 Financial Results - Accesswire
- 5 weeks ago - Ainos to Participate in Fireside Chat with Water Tower Research on August 20, 2025 - Accesswire
- 6 weeks ago - Ainos Secures $2.1 Million Order With ASE for First Deployment of AI Nose in Semiconductor Manufacturing Setting - Accesswire